01 1Aurobindo Pharma Limited
02 1Cambrex Karlskoga AB
03 1Erregierre SpA
04 1Jubilant Pharmova Limited
05 1MYLAN LABORATORIES LIMITED
01 2RIVASTIGMINE
02 2Rivastigmine
03 1rivastigmine
01 2India
02 1Italy
03 2U.S.A
NDC Package Code : 65862-982
Start Marketing Date : 2023-11-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12651-118
Start Marketing Date : 2017-02-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49706-1825
Start Marketing Date : 2013-10-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1153
Start Marketing Date : 2011-01-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-819
Start Marketing Date : 2015-03-02
End Marketing Date : 2025-12-01
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Rivastigmine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rivastigmine, including repackagers and relabelers. The FDA regulates Rivastigmine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rivastigmine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rivastigmine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rivastigmine supplier is an individual or a company that provides Rivastigmine active pharmaceutical ingredient (API) or Rivastigmine finished formulations upon request. The Rivastigmine suppliers may include Rivastigmine API manufacturers, exporters, distributors and traders.
click here to find a list of Rivastigmine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rivastigmine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rivastigmine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rivastigmine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rivastigmine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rivastigmine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rivastigmine suppliers with NDC on PharmaCompass.
We have 5 companies offering Rivastigmine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
